InspireMD Inc. (NSPR) Earnings Call Analysis
NASDAQ · Healthcare · Medical Devices
Earnings Reports
-
InspireMD (NSPR) Q1 2026: U.S. Commercial Pause Halts Guidance Despite 122% Revenue Surge
May 05, 2026
-
InspireMD (NSPR) Q4 2025: U.S. Revenue Jumps 74% Sequentially as C-Guard Prime Gains Traction
March 18, 2026
-
InspireMD (NSPR) Q3 2025: U.S. Launch Drives 39% Revenue Growth, Margin Leverage Building
November 04, 2025
-
InspireMD (NSPR) Q2 2025: $58M Capital Infusion Powers U.S. Launch Momentum
August 05, 2025
-
InspireMD (NSPR) Q2 2025: $58M Capital Infusion Fuels U.S. C-Guard Prime Launch Ramp
August 05, 2025